FDA Inspection 844221 — Opada Alzohaili, M.D.
The FDA completed an inspection of Opada Alzohaili, M.D. on August 14, 2013 in Dearborn, MI. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 14, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dearborn, MI (United States)
Additional Details
Clinical Investigator (CI)